| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
61,398,000 |
| Market
Cap: |
304.53(M) |
| Last
Volume: |
907,467 |
Avg
Vol: |
710,310 |
| 52
Week Range: |
$3.38 - $6.5 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Vanda Pharmaceuticals is a biopharmaceutical company. Co.'s commercial portfolio is comprised of two products, HETLIOZ® for the treatment of Non-24 Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome and Fanapt® for the treatment of schizophrenia. In addition, Co. has a number of drugs in development, including: Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist, for the treatment of gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia; and VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for several oncology indications.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
2,251 |
2,251 |
123,349 |
363,323 |
| Total Sell Value |
$13,327 |
$13,327 |
$526,672 |
$2,473,859 |
| Total People Sold |
1 |
1 |
5 |
6 |
| Total Sell Transactions |
1 |
1 |
11 |
29 |
| End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Moran Kevin Patrick |
SVP, CFO & Treasurer |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
32,700 |
131,996 |
|
- |
|
| Williams Timothy |
SVP & General Counsel |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
32,700 |
115,911 |
|
- |
|
| Jones Aranthan Ii |
Chief Corp. Affairs Officer |
• – – |
2021-09-15 |
4 |
S |
$16.49 |
$277,394 |
D/D |
(16,824) |
81,980 |
|
- |
|
| Jones Aranthan Ii |
Chief Corp. Affairs Officer |
• – – |
2021-09-15 |
4 |
OE |
$11.32 |
$141,250 |
D/D |
12,119 |
98,804 |
|
- |
|
| Mitchell Stephen Ray |
Director |
– • – |
2021-09-09 |
4 |
S |
$16.74 |
$319,976 |
D/D |
(19,109) |
9,215 |
|
- |
|
| Mitchell Stephen Ray |
Director |
– • – |
2021-09-09 |
4 |
OE |
$10.57 |
$229,936 |
D/D |
19,109 |
28,324 |
|
- |
|
| Wijkstrom Joakim |
SVP, Chief Marketing Officer |
• – – |
2021-08-20 |
4 |
S |
$15.39 |
$56,190 |
D/D |
(3,650) |
74,552 |
|
- |
|
| Williams Timothy |
SVP & General Counsel |
• – – |
2021-08-16 |
4 |
S |
$16.15 |
$59,989 |
D/D |
(3,715) |
83,211 |
|
- |
|
| Moran Kevin Patrick |
SVP, CFO & Treasurer |
• – – |
2021-07-28 |
4 |
S |
$19.24 |
$40,973 |
D/D |
(2,130) |
99,296 |
|
- |
|
| Jones Aranthan Ii |
Chief Corp. Affairs Officer |
• – – |
2021-07-26 |
4 |
S |
$19.69 |
$142,776 |
D/D |
(7,250) |
86,685 |
|
- |
|
| Mitchell Stephen Ray |
Director |
– • – |
2021-06-15 |
4 |
S |
$19.42 |
$97,122 |
D/D |
(5,000) |
9,215 |
|
- |
|
| Mitchell Stephen Ray |
Director |
– • – |
2021-06-15 |
4 |
OE |
$10.57 |
$42,439 |
D/D |
4,015 |
14,215 |
|
- |
|
| Chrousos Phaedra |
Director |
– • – |
2021-06-14 |
4 |
S |
$19.34 |
$40,132 |
D/D |
(2,075) |
12,925 |
|
- |
|
| Watkins Thomas |
Director |
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
54,505 |
|
- |
|
| Chrousos Phaedra |
Director |
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
15,000 |
|
- |
|
| Mitchell Stephen Ray |
Director |
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
10,200 |
|
- |
|
| Ward Anne Sempowski |
Director |
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
10,000 |
|
- |
|
| Dugan Richard W |
Director |
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
59,887 |
|
- |
|
| Jones Aranthan Ii |
Chief Corp. Affairs Officer |
• – – |
2021-03-15 |
4 |
S |
$17.72 |
$319,010 |
D/D |
(18,000) |
93,935 |
|
- |
|
| Jones Aranthan Ii |
Chief Corp. Affairs Officer |
• – – |
2021-03-15 |
4 |
OE |
$11.32 |
$169,800 |
D/D |
15,000 |
111,935 |
|
- |
|
| Polymeropoulos Mihael Hristos |
President and CEO |
• • – |
2021-03-08 |
4 |
S |
$18.00 |
$3,150,053 |
D/D |
(175,000) |
1,221,062 |
|
- |
|
| Williams Timothy |
SVP & General Counsel |
• – – |
2021-03-05 |
4 |
S |
$17.85 |
$99,966 |
D/D |
(5,600) |
86,926 |
|
- |
|
| Polymeropoulos Mihael Hristos |
President and CEO |
• • – |
2021-03-02 |
4 |
S |
$18.34 |
$278,902 |
D/D |
(15,206) |
1,396,062 |
|
- |
|
| Wijkstrom Joakim |
SVP, Chief Marketing Officer |
• – – |
2021-03-02 |
4 |
S |
$18.45 |
$71,729 |
D/D |
(3,888) |
78,202 |
|
- |
|
| Jones Aranthan Ii |
Chief Corp. Affairs Officer |
• – – |
2021-03-02 |
4 |
S |
$18.04 |
$69,717 |
D/D |
(3,865) |
96,935 |
|
- |
|
277 Records found
|
|
Page 4 of 12 |
|
|
0.21 (4.42%) 
